Skip to content

Prognostic lncRNAs and their functional pathways in gastric cancer revealed by bioinformatics and experimental validation

Sep 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 34 references
Medicine

TL;DR

Higher expression of all six lncRNAs in gastric cancer was associated with unfavourable overall survival and co-expression enrichment identified several cancer-associated pathways, most prominently epithelial–mesenchymal transition.

View source

Similar papers

Open access Jan 2026

Integrative Pan‐Cancer Characterization of lncRNA UPK1A‐AS1 and Its Role in Hypoxia‐Associated Sorafenib Resistance in Hepatocellular Carcinoma

It is suggested that UPK1A-AS1 is a hypoxia‐inducible oncogenic lncRNA that plays dual roles in cancer, with cancer type‐dependent associations with progression and immune modulation across malignancies and mechanistically mediating hypoxia‐associated drug resistance in HCC.

Ze-Kai Li, Min Luo, Shu-Sen Fang et al. · 0 citations
Open access Aug 2026

Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients

This computational study identifies several candidate lncRNAs associated with clinical outcomes in breast cancer, which should be interpreted as preliminary candidates, which require future validation and functional studies to determine their biological roles and evaluate their potential as prognostic biomarkers.

M. Acencio, Xin-Hui Wang, Flavia R. Rotea Mangone et al. · 0 citations
Aug 2026

Elevated Expression of LINC02257 and LINC00659 in Breast Cancer is Associated with Poor Survival and Immune Cell Infiltration

This study found that LINC02257 and LINC00659 are upregulated in BC and are associated with malignancy-related genes and patient survival, suggesting their potential as therapeutic targets and prognostic biomarkers.

Fatemeh Badzohre, Azin Azadfekr, Farnoosh Akbari et al. · 0 citations
Open access Aug 2026

Anoikis associated long noncoding RNA signature predicts prognosis and small molecule drug response in glioma across multiple databases

The established eight-ARlncRNA signature serves as a robust prognostic tool, effectively predicting patient survival and mirroring the heterogeneity of the tumor immune landscape, and offers potential guidance for personalizing therapeutic strategies in glioma.

Yuting Ouyang, Rui Han, An-Qi Song et al. · 0 citations
Open access Aug 2026

Prognostic significance of the TMPO-AS1/ hsa-let-7b-5p axis and nTreg infiltration in lung adenocarcinoma: an in silico analysis

A robust G2/M -associated regulatory framework in LUAD is defined, characterized by reciprocal dysregulation of oncogenes and tumor suppressors and associated with the predicted TMPO-AS1–hsa-let-7b-5p regulatory network, which is linked to a less immunosuppressive tumor microenvironment, offering potential prognostic a...

Prerna Vats, Bhavika Baweja, Chainsee Saini et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.